Lineage Cell Therapeutics
LCTX
LCTX
80 hedge funds and large institutions have $152M invested in Lineage Cell Therapeutics in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 8 closing their positions.
Holders
80
Holders Change
+6
Holders Change %
+8.11%
% of All Funds
2.14%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
14
Increased
27
Reduced
10
Closed
8
Calls
$103K
Puts
$318K
Net Calls
-$215K
Net Calls Change
+$26K
Top Buyers
1 |
BFA
1
BlackRock Fund Advisors
San Francisco,
California
|
$7.61M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$10.3M |
3 |
3
Jane Street
New York
|
$330K |
4 |
4
State Street
Boston,
Massachusetts
|
$3.73M |
5 |
5
D.E. Shaw & Co
New York
|
$319K |